212 related articles for article (PubMed ID: 20950330)
1. Lacosamide and epilepsy.
Harris JA; Murphy JA
CNS Neurosci Ther; 2011 Dec; 17(6):678-82. PubMed ID: 20950330
[TBL] [Abstract][Full Text] [Related]
2. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
Saussele T
Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
Harris JA; Murphy JA
Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
[TBL] [Abstract][Full Text] [Related]
4. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
[TBL] [Abstract][Full Text] [Related]
5. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
6. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
Ben-Menachem E
Drugs Today (Barc); 2008 Jan; 44(1):35-40. PubMed ID: 18301802
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
[TBL] [Abstract][Full Text] [Related]
8. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.
Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J
CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
10. Development of lacosamide for the treatment of partial-onset seizures.
Doty P; Hebert D; Mathy FX; Byrnes W; Zackheim J; Simontacchi K
Ann N Y Acad Sci; 2013 Jul; 1291(1):56-68. PubMed ID: 23859801
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide for the treatment of epilepsy.
Krauss GL; Edwards HB; Lin B
Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
Pasha I; Kamate M; Didagi SK
Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
Scott LJ
Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide add-on therapy for partial epilepsy.
Weston J; Shukralla A; McKay AJ; Marson AG
Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
[TBL] [Abstract][Full Text] [Related]
19. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
[TBL] [Abstract][Full Text] [Related]
20. Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures.
Hoy SM
CNS Drugs; 2013 Dec; 27(12):1125-42. PubMed ID: 24203890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
